Clinical Research Progress in the Treatment and Prognosis of Comorbid Coronary Heart Disease and Lung Cancer
Jiale Li, Yancai Kang, Fan Zhou, Junsheng Mu · 2026
Read Clinical Research Progress in the Treatment and Prognosis of Comorbid Coronary Heart Disease and Lung Cancer by Jiale Li, Yancai Kang, Fan Zhou, Junsheng Mu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13339171.txt.
Description
Jiale Li, Yancai Kang, Fan Zhou, and Junsheng Mu review care when heart disease and lung cancer occur together in a 2026 article. Both diseases share risks such as smoking, and patient numbers grow with aging. Cancer surgery strains the heart, while heart drugs raise bleeding risk.
Recent decade literature guides staged choices. Early cancer with mild heart disease and good function may allow combined surgery. Advanced cancer or complex heart disease favors staged care with smaller incisions. Radiation dose and clot prevention need balancing in non-surgical care. Low inflammation, heavy calcium, high SYNTAX scores, and diabetes flag poorer outlooks as reviewed.
Catalog record
| CREATOR | Jiale Li, Yancai Kang, Fan Zhou, Junsheng Mu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37580 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |